FDA: Serological Tests Not Sufficient To Diagnose COVID-19
Directly from the FDA today (4/21/2020) "Health care providers should be aware of the limitations of serological tests intended to detect antibodies to SARS-CoV-2 and the risks to patients and the community if the test results are used as the sole basis to diagnose COVID-19.
The FDA is not aware of an antibody test that has been validated for diagnosis of SARS-CoV-2 infection. While the FDA remains open to receiving submissions for these tests for such uses, based on the underlying scientific principles of antibody tests, the FDA does not expect that an antibody test can be shown to definitively diagnose or exclude SARS-CoV-2 infection."
#FDA #COVID19 #Fibromyalgia #CheckInWithMe #MightyTogether #flattenthecurve #stayathome #ComplexUnspecifiedNeuromuscularDisease #quarantine #WritingThroughIt